SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-24-000145
Filing Date
2024-08-07
Accepted
2024-08-07 16:13:40
Documents
83
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-20240630.htm   iXBRL 10-Q 1305520
2 EX-31.1 CEO CERTIFICATION plrx-20240630xex311.htm EX-31.1 9814
3 EX-31.2 CFO CERTIFICATION plrx-20240630xex312.htm EX-31.2 9782
4 EX-32.1 CEO AND CFO CERTIFICATION plrx-20240630xex321.htm EX-32.1 7288
  Complete submission text file 0001746473-24-000145.txt   6636999

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20240630.xsd EX-101.SCH 51979
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20240630_cal.xml EX-101.CAL 59246
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20240630_def.xml EX-101.DEF 245536
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20240630_lab.xml EX-101.LAB 627651
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20240630_pre.xml EX-101.PRE 457081
85 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20240630_htm.xml XML 709730
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 241183916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)